Pulmuone Corporate Stock

Equities

A017810

KR7017810003

Food Processing

End-of-day quote Korea S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
13,590 KRW +1.12% Intraday chart for Pulmuone Corporate +2.95% +29.55%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 2,838B 2.08B Sales 2023 2,993B 2.19B Capitalization 386B 283M
Net income 2022 -18.6B -13.64M Net income 2023 19.52B 14.31M EV / Sales 2022 0.42 x
Net Debt 2022 788B 577M Net Debt 2023 940B 689M EV / Sales 2023 0.44 x
P/E ratio 2022
-15.5 x
P/E ratio 2023
48.6 x
Employees 478
Yield 2022
0.91%
Yield 2023
0.97%
Free-Float 23.85%
More Fundamentals * Assessed data
Dynamic Chart
Korean Food Companies Boost R&D as Ramyun, Dumplings Gain Popularity MT
Pulmuone Corporate Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Pulmuone Corporate Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pulmuone Corporate announced that it has received KRW 100 billion in funding from IBK-Kiwoomp Business Recorganizaion Private Equity Fund Co., Ltd, Kiwoom Investment Co., Ltd., Lohas Private Equity Fund Co., Ltd CI
Pulmuone Corporate announced that it expects to receive KRW 100 billion in funding from IBK-Kiwoomp Business Recorganizaion Private Equity Fund Co., Ltd, Kiwoom Investment Co., Ltd., Lohas Private Equity Fund Co., Ltd CI
Pulmuone Corporate Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pulmuone Corporate Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pulmuone Corporate Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pulmuone Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Pulmuone Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pulmuone Raises Tofu Production Capacity in China with New Facility MT
Pulmuone Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pulmuone Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Thai Union Public : Lab-grown fish fingers anyone? Birds Eye owner explores cell-cultured seafood RE
Market Chatter: Pulmuone Subsidiary Names Former LG Executive as New CEO MT
More news
1 day+1.12%
1 week+2.95%
Current month+10.76%
1 month+15.96%
3 months+30.17%
6 months+27.97%
Current year+29.55%
More quotes
1 week
12 730.00
Extreme 12730
15 140.00
1 month
11 680.00
Extreme 11680
15 140.00
Current year
9 960.00
Extreme 9960
15 140.00
1 year
9 330.00
Extreme 9330
15 140.00
3 years
9 330.00
Extreme 9330
23 000.00
5 years
7 120.00
Extreme 7120
25 000.00
10 years
7 120.00
Extreme 7120
26 900.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 -
Founder 72 -
Director of Finance/CFO 57 -
Members of the board TitleAgeSince
Founder 72 -
Chief Executive Officer 67 -
Corporate Officer/Principal 68 -
More insiders
Date Price Change Volume
24-05-20 13,590 +1.12% 325 658
24-05-20 13,440 -2.33% 689,256
24-05-17 13,760 +7.25% 4,883,905
24-05-16 12,830 -0.93% 95,583
24-05-14 12,950 -1.89% 112,738

End-of-day quote Korea S.E., May 20, 2024

More quotes
PULMUONE, formerly Pulmuone Holdings Co., Ltd. is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company is mainly engaged in the food manufacturing and food material distribution businesses. The Company’s subsidiaries include Pulmuone Foods Co., Ltd., which is engaged in the production of tofu, bean sprouts, eggs and noodles; Exofresh Logistics Co., Ltd., which is mainly engaged in the provision of chilled logistic business; ECMD. CO., LTD., which is engaged in the food service business; FOODMERCE, which is engaged in the distribution of food materials, and Pulmuone Health&Living CO.LTD., which is mainly engaged in the manufacture of healthcare foods.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A017810 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW